253 related articles for article (PubMed ID: 31487529)
1. The potential use of mesenchymal stem cells for the treatment of multiple sclerosis.
Mansoor SR; Zabihi E; Ghasemi-Kasman M
Life Sci; 2019 Oct; 235():116830. PubMed ID: 31487529
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination.
El-Akabawy G; Rashed LA
Ann Anat; 2015 Mar; 198():11-20. PubMed ID: 25660362
[TBL] [Abstract][Full Text] [Related]
3. The transplantation of mesenchymal stem cells derived from unconventional sources: an innovative approach to multiple sclerosis therapy.
Giacoppo S; Bramanti P; Mazzon E
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):363-379. PubMed ID: 28342084
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell transplantation in multiple sclerosis.
Cohen JA
J Neurol Sci; 2013 Oct; 333(1-2):43-9. PubMed ID: 23294498
[TBL] [Abstract][Full Text] [Related]
5. A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis.
Shokati A; Naser Moghadasi A; Nikbakht M; Sahraian MA; Mousavi SA; Ai J
Stem Cell Res Ther; 2021 Jul; 12(1):400. PubMed ID: 34256857
[TBL] [Abstract][Full Text] [Related]
6. Effects of mesenchymal stem cells transplantation on multiple sclerosis patients.
Barati S; Tahmasebi F; Faghihi F
Neuropeptides; 2020 Dec; 84():102095. PubMed ID: 33059244
[TBL] [Abstract][Full Text] [Related]
7. Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis.
Rivera FJ; Aigner L
Biol Res; 2012; 45(3):257-68. PubMed ID: 23283435
[TBL] [Abstract][Full Text] [Related]
8. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
Harris VK; Vyshkina T; Sadiq SA
Cytotherapy; 2016 Dec; 18(12):1476-1482. PubMed ID: 27727015
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.
Karussis D; Kassis I; Kurkalli BG; Slavin S
J Neurol Sci; 2008 Feb; 265(1-2):131-5. PubMed ID: 17610906
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell Therapy for Multiple Sclerosis.
Genc B; Bozan HR; Genc S; Genc K
Adv Exp Med Biol; 2019; 1084():145-174. PubMed ID: 30039439
[TBL] [Abstract][Full Text] [Related]
11. Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection.
Yousefi F; Lavi Arab F; Saeidi K; Amiri H; Mahmoudi M
J Neuroimmunol; 2019 Mar; 328():20-34. PubMed ID: 30557687
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases.
Uccelli A; Laroni A; Freedman MS
Lancet Neurol; 2011 Jul; 10(7):649-56. PubMed ID: 21683930
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
Rozier P; Maria A; Goulabchand R; Jorgensen C; Guilpain P; Noël D
Front Immunol; 2018; 9():2938. PubMed ID: 30619298
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
de Oliveira GL; de Lima KW; Colombini AM; Pinheiro DG; Panepucci RA; Palma PV; Brum DG; Covas DT; Simões BP; de Oliveira MC; Donadi EA; Malmegrim KC
Cell Transplant; 2015; 24(2):151-65. PubMed ID: 24256874
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter?
Uccelli A; Morando S; Bonanno S; Bonanni I; Leonardi A; Mancardi G
Curr Stem Cell Res Ther; 2011 Mar; 6(1):69-72. PubMed ID: 20955153
[TBL] [Abstract][Full Text] [Related]
16. Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis.
Wang X; Kimbrel EA; Ijichi K; Paul D; Lazorchak AS; Chu J; Kouris NA; Yavanian GJ; Lu SJ; Pachter JS; Crocker SJ; Lanza R; Xu RH
Stem Cell Reports; 2014 Jul; 3(1):115-30. PubMed ID: 25068126
[TBL] [Abstract][Full Text] [Related]
17. CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells.
Sargent A; Bai L; Shano G; Karl M; Garrison E; Ranasinghe L; Planchon SM; Cohen J; Miller RH
Exp Neurol; 2017 Sep; 295():222-232. PubMed ID: 28602834
[TBL] [Abstract][Full Text] [Related]
18. Effect of Multiple Intraperitoneal Injections of Human Bone Marrow Mesenchymal Stem Cells on Cuprizone Model of Multiple Sclerosis.
Marzban M; Mousavizadeh K; Bakhshayesh M; Vousooghi N; Vakilzadeh G; Torkaman-Boutorabi A
Iran Biomed J; 2018 Sep; 22(5):312-21. PubMed ID: 29409311
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.
Gharibi T; Ahmadi M; Seyfizadeh N; Jadidi-Niaragh F; Yousefi M
Cell Immunol; 2015 Feb; 293(2):113-21. PubMed ID: 25596473
[TBL] [Abstract][Full Text] [Related]
20. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
